Search Results 801-810 of 18227 for creatine evidence

  1. Neurology - Clinical trials - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  2. A Study to Develop a Hypertrophic Cardiomyopathy Registry - Mayo Clinic

    ... evidence base to later enable clinical trial design to reduce the morbidity and mortality of HCM in a cost-effective manner. Participation eligibility.

  3. An Investigational Drug (TPST-1495) In Patients With Familial Adenomatous Polyposis - Mayo Clinic

    * Creatinine ≤ institutional ULN * Urinary ... * Patients with evidence of human ... * Patients with evidence of chronic hepatitis B virus (HBV) or ...

  4. Study of bb21217 in Multiple Myeloma - Mayo Clinic

    Inadequate renal function defined by creatinine clearance ≤ 5 mL/min using the Cockcroft-Gault formula. ... Known hepatitis A virus (HAV), hepatitis B virus (HBV) ...

  5. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Evidence of metastasis on prostate-specific membrane antigen positron ... Adequate renal function (creatinine clearance >50 mL/min by serum creatinine).

  6. A Study to Evaluate Olaparib and Temozolomide in Treating Patients With Advanced, Metastatic, or Unresectable Uterine Leiomyosarcoma - Mayo Clinic

    If patients have evidence of chronic hepatitis B virus (HBV) infection, HBV viral load must be undetectable on suppressive therapy if indicated. Patients ...

  7. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    ... evidence of transformation to large cell histology. Patient must meet ... Creatinine clearance ≥ 50 mL/min, calculated with the use of 24-hour creatinine ...

  8. MEmbranous Nephropathy Trial Of Rituximab - Mayo Clinic

    Patients with documented evidence of >3 months treatment with maximal angiotensin II blockade, on an HMG-CoA reductase inhibitor, and BP control (BP <140/80 ...

  9. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Aspartate aminotransferase (AST) ≤ 3 x ULN unless evidence of the direct liver involvement by lymphoma - then ≤ 5 x ULN; Creatinine ≤ 2 x ULN or creatinine ...

  10. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    No evidence of invasive cancer or DCIS at the surgical resection margins · No gross residual adenopathy · Planning to undergo radiation therapy to the breast with ...